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Abstract 1 
Metabolic stress evoked by myocardial ischemia leads to impairment of cardiac excitation 2 
and contractility. We studied the mechanisms by which metabolic inhibition affects the 3 
activity of L-type Ca2+ channels (LTCCs) in frog ventricular myocytes. Metabolic inhibition 4 
induced by the protonophore FCCP (as well as by 2,4- dinitrophenol, sodium azide or 5 
antimycin A) resulted in a dose-dependent reduction of LTCC current (ICa,L) which was more 6 
pronounced during β-adrenergic stimulation with isoprenaline. ICa,L was still reduced by 7 
metabolic inhibition even in the presence of 3 mM intracellular ATP, or when the cell was 8 
dialysed with cAMP or ATP-γ-S to induce irreversible thiophosphorylation of LTCCs, 9 
indicating that reduction in ICa,L is not due to ATP depletion and/or reduced phosphorylation 10 
of the channels. However, the effect of metabolic inhibition on ICa,L was strongly attenuated 11 
when the mitochondrial F1F0-ATP-synthase was blocked by oligomycin or when the cells 12 
were dialysed with the non-hydrolysable ATP analogue AMP-PCP. Moreover, increasing the 13 
intracellular pH buffering capacity or intracellular dialysis of the myocytes with an alkaline 14 
solution strongly attenuated the inhibitory effect of FCCP on ICa,L. Thus, our data demonstrate 15 
that metabolic inhibition leads to excessive ATP hydrolysis by the mitochondrial F1F0-ATP-16 
synthase operating in the reverse mode and this results in intracellular acidosis causing the 17 
suppression of ICa,L. Limiting ATP break-down by F1F0-ATP-synthase and the consecutive 18 
development of intracellular acidosis might thus represent a potential therapeutic approach 19 
for maintaining a normal cardiac function during ischemia. 20 
  21 
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Introduction 22 
Mitochondria play a central role in cellular energy production and Ca2+ homeostasis. 23 
During myocardial ischemia, mitochondria undergo progressive damage, including dramatic 24 
decrease in the activity of oxidative-phosphorylation complexes [1]. The resulting metabolic 25 
stress disrupts intracellular Ca2+ cycling via alterations in sarcoplasmic reticulum (SR) Ca2+ 26 
load [2-5], causing an impairment of excitation-contraction coupling (ECC) and cardiac 27 
contractility [6, 7]. In addition, ischemia leads to heterogeneities in cardiac excitability and 28 
refractoriness and creates a substrate for ectopic excitation that can trigger lethal ventricular 29 
arrhythmias [8, 9]. 30 
L-type Ca2+ channel current triggers the release of Ca2+ from the SR. Alterations in the 31 
density or function of LTCCs have been implicated in a variety of cardiovascular diseases, 32 
including atrial fibrillation [10, 11], heart failure [12] and ischemic heart disease [13]. While 33 
several studies showed that metabolic inhibition as occurs during ischemia induces a decrease 34 
in the amplitude of ICa,L [14, 15], the underlying mechanisms remain poorly understood. 35 
Metabolic inhibition results in multiple and complex changes in cardiomyocytes such as fall 36 
of ATP levels [16], elevation in inorganic phosphate, ADP, free Mg2+ [3, 17] and Ca2+ [18] 37 
concentrations and intracellular acidification [3, 19, 20], all of which could affect the activity 38 
of LTCCs. In addition, a close proximity or even tethering of mitochondria to 39 
endo/sarcoplasmic reticulum and plasma membrane has been documented in several cell 40 
types [21, 22]. These organelles may therefore form restricted domains with elevated changes 41 
in metabolite and ion concentrations that could intensify the effects on the activity of ion 42 
channels. 43 
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The aim of this study was to investigate the mechanisms by which metabolic inhibition 44 
causes a reduction in ICa,L. The experiments were performed in frog cardiomyocytes rather 45 
than mammalian cardiomyocytes, because in these cells LTCCs are the primary source of 46 
Ca2+ for contraction and Ca2+ release from the SR plays only a minor role [23, 24]. We found 47 
that during metabolic inhibition the amplitude of both basal and stimulated ICa,L was 48 
significantly attenuated. This effect was at least partially reversed by the inhibition of 49 
mitochondrial F1F0-ATP synthase or intracellular dialysis with non-hydrolysable ATP 50 
analogues. We demonstrate that metabolic inhibition effect is dependent on the intracellular 51 
acidification of the cardiomyocytes presumably resulting from the reverse-mode activity of 52 
F1F0-ATP synthase. 53 
Materials and methods 54 
Animals and myocyte isolation 55 
All procedures were approved by the State Food and Veterinary Service of the Republic 56 
of Lithuania and comply with the Guide for the Care and Use of Laboratory Animals of the 57 
National Institutes of Health and UK regulations on animal experimentation [25]. Ventricular 58 
cells were enzymatically dispersed from frog (Rana esculenta, 18 frogs in total) heart. Frogs 59 
were purchased from the Etablissements Guy Couétard (La Fradinière, Saint Hilaire de Riez, 60 
France) where the animals were bred for research purposes. For the preparation of frog 61 
ventricular myocytes, the ionic composition of Ca2+-free Ringer solution was (in mM): 88.4 62 
NaCl; 2.5 KCl; 23.8 NaHCO3; 0.6 NaH2PO4; 1.8 MgCl2; 5 creatine; 10 D-glucose; pH 7.4. 63 
Frogs were euthanized by concussion. The heart was removed and submersed in cold Ca2+-64 
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free Ringer solution (4–8oC) supplemented with 80 M CaCl2. Then the heart was mounted 65 
on a Langendorff apparatus and perfused at 5 ml/min at 30°C with a series of solutions based 66 
on a Ca2+-free Ringer solution. At first, the heart was perfused for 8–10 min with Ca2+-free 67 
Ringer solution containing 20 µM of EGTA and 1 mg/ml fatty acid-free bovine serum 68 
albumin (BSA). After that, perfusion was switched to the isolation solution composed of 69 
Ca2+-free Ringer solution with 0.2 mg/ml of trypsin type XIII (Sigma-Aldrich, Schnelldorf, 70 
Germany), 0.14 mg/ml of collagenase (Yakult S, Tokyo, Japan) and 1 mg/ml of BSA added. 71 
Perfusion lasted for 10–12 min at 30°C. The solution was then changed to a fresh enzymatic 72 
solution, and the heart was perfused for another 10-12 min period. Finally, the ventricle was 73 
dissected and the cells were dispersed in a flask containing a Ca2+-free Ringer solution 74 
supplemented with 80 M CaCl2. Isolated cells were stored at 4°C in storage Ringer solution 75 
composed of Ca2+-free Ringer solution supplemented with: 1 mM CaCl2, 10 µl/ml non-76 
essential and essential amino acid and vitamin solution (MEM 100x), and antibiotics (200 77 
u/ml penicillin and 0.2 mg/ml streptomycin). 78 
Electrophysiology 79 
A few drops of cell suspension were placed in a perfusion chamber mounted on an 80 
inverted microscope stage. After the cells had settled to the bottom, the chamber was 81 
superfused with K+ free control external solution containing (in mM): 107 NaCl;10 HEPES; 82 
20 CsCl; 4 NaHCO3; 0.8 NaH2PO4; 1.8 MgCl2; 1.8 CaCl2; 5 D-glucose; 5 sodium pyruvate; 83 
pH 7.4 was adjusted with NaOH. Patch pipettes were made from glass capillaries 84 
(Drummond, Broomall, PA, USA) and had resistances of 0.7-1.2 M when filled with 85 
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control internal solution. The myocytes were dialysed with control internal solution 86 
composed of (in mM): 120 CsCl, 5 EGTA (acid form), 4 MgCl2, 0.062 CaCl2, 5 creatine 87 
phosphate disodium salt, 3 Na2ATP, 0.42 Na2GTP and 10 HEPES; pH 7.3 was adjusted with 88 
CsOH. External control or drug-containing solutions were applied to the myocyte by placing 89 
the cell at the opening of capillary tubing (800 m in inner diameter) flowing at a rate of 90 
150 l/min. Changes in extracellular solutions were automatically achieved by a rapid 91 
solution changer (RSC100, Bio-Logic, France). ICa,L was recorded under the whole-cell 92 
configuration of the patch-clamp technique. ICa,L was activated every 8 s by depolarizing 93 
voltage clamp steps from –80 mV holding potential to 0 mV for 200 ms. ICa,L amplitude was 94 
measured as the difference between peak inward current and the current at the end of the 200 95 
ms pulse. Application of tetrodotoxin (3 M) was used to inactivate voltage-dependent Na+ 96 
currents. K+ currents were blocked by replacing all intracellular and extracellular K+ ions 97 
with Cs+. The cells were voltage-clamped using a patch-clamp amplifier RK-400 (Bio-Logic, 98 
Claix, France). Currents were sampled at a frequency of 10 kHz using a 16-bit analogue-to-99 
digital converter (PCL816, Advantech France, Levallois-Perret, France). Liquid junction 100 
potentials between internal and external solutions were compensated before pipette touched 101 
the cell. Currents were not compensated for capacitive and leak currents.  102 
To determine current-voltage (I-V) relationship and inactivation of ICa,L, a double pulse 103 
voltage-clamp protocol was applied every 4 seconds (see insert in Fig. 1C). During the first 104 
pulse S1, the membrane potential was set at membrane potentials ranging from -100 to +100 105 
mV for 200 ms. S1 pulse was followed by a 3 ms repolarization to the -80 mV holding 106 
potential and then a depolarizing pulse S2 to 0 mV was applied for 200 ms. 107 
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All experiments were performed at room temperature (18–24oC), and the temperature 108 
did not change by more than 1oC during an experiment. 109 
Drugs and reagents 110 
Tetrodotoxin was from Latoxan (Rosans, France). All other drugs were purchased from 111 
Sigma-Aldrich (Schnelldorf, Germany) unless otherwise indicated. Each day, fresh 1-10 mM 112 
stock solutions were prepared and stored at 4°C. FCCP (p-trifluoromethoxy carbonyl cyanide 113 
phenyl hydrazone) was dissolved in ethanol, DNP (2,4-dinitrophenol) and antimycin A in 114 
DMSO. The stock solution of oligomycin was prepared in ethanol. To improve its solubility, 115 
the control external solution was heated to 50oC and appropriate amounts of stock solution 116 
of oligomycin were then added. All other drugs were dissolved in water based solutions. 117 
When the stock solutions were obtained in DMSO or ethanol, the corresponding amount of 118 
solvent was also added to the control external solution. 119 
Data and statistics analysis 120 
Error bars are given as standard errors to the mean (S.E.M.). The number of cells is 121 
denoted by n. For statistical evaluation the paired and unpaired Student’s t-test were used, 122 
and a difference was considered statistically significant with P<0.05. In the text, “basal ICa,L” 123 
refers to the Ca2+ current which was not stimulated by -adrenergic stimulation or 124 
intracellular cAMP. 125 
126 
 7  
Results 127 
Effect of metabolic inhibitors on ICa,L 128 
The first series of experiments were set to determine the effect of metabolic inhibition 129 
on ICa,L in frog ventricular myocytes. The mitochondrial uncoupler carbonyl cyanide p- 130 
[trifluoromethoxy]-phenyl-hydrazone (FCCP) had no significant effect on basal ICa,L at 30 to 131 
70 nM but reduced the current at 100 nM concentration by 22.1 ± 9.6% (n=5, P<0.05, 132 
Supplemental S1 Fig). When ICa,L was enhanced by the β-adrenergic agonist isoprenaline 133 
(ISO, 1 M), the inhibitory effect of FCCP was more pronounced, and was already significant 134 
at 70 nM. At 100 nM concentration, FCCP suppressed the ISO-stimulated ICa,L by 135 
70.4 ± 6.6% (n=7, P<0.05) (Fig 1A and 1B). Application of FCCP had no major effect on the 136 
shape of the ICa,L I-V relationship (Fig 1Ca) or inactivation curve (Fig 1Cb).To examine 137 
whether the inhibitory effect of FCCP on ICa,L was due to inhibition of oxidative 138 
phosphorylation, other metabolic inhibitors were tested. 2,4- dinitrophenol (DNP, 100 µM), 139 
another uncoupler of oxidative phosphorylation, caused a similar reduction of ISO-stimulated 140 
ICa,L as 100 nM FCCP (60.9 ± 8.7% inhibition, n=5, P<0.05) (Fig 2). Sodium azide (NaN3, 3 141 
mM), an inhibitor of respiratory chain complex IV, or antimycin A (30 nM), an inhibitor of 142 
complex III, decreased basal ICa,L by 46.6 ± 13.6% (n=3, P<0.05) and 71.9 ± 2.4% (n=4, 143 
P<0.01), and ISO-stimulated ICa,L by 66.3 ± 5.4% (n=4, P<0.05) and 62.5 ± 2.9% (n=6, 144 
P<0.05), respectively (Fig 2 and experimental traces are shown in supplemental S2 Fig). 145 
These results demonstrate that various metabolic inhibitors, with different structures and 146 
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targets cause a decrease of basal and stimulated ICa,L, indicating that inhibition of oxidative 147 
phosphorylation suppresses the activity of LTCCs. 148 
 149 
Fig 1. Effect of FCCP on isoprenaline stimulated ICa,L. (A) Effect of FCCP on isoprenaline 150 
(ISO, 1 µM)-stimulated ICa,L. Traces of ICa,L shown on the top were recorded at the times 151 
indicated by the corresponding letters on the main graph. (B) Concentration-response curve 152 
for the effect of FCCP on ISO-stimulated ICa,L. (C) Current-voltage (I-V) relationships (a) 153 
and inactivation curves (b) of ICa,L under basal conditions, during ISO (1 µM) stimulation 154 
and during exposure to two different FCCP concentrations (70 and 100 nM) in the presence 155 
of ISO. Inset: Double-pulse protocol used for the inactivation curves (see Methods for 156 
details). ICa,L peak amplitude during S2 pulse is expressed as a percentage of ICa,L measured 157 
at 0 mV without conditioning pulse S1 and plotted as a function of S1 pulse potential. 158 
 159 
Fig. 2. Effect of various metabolic inhibitors on isoprenaline stimulated ICa,L. 160 
Peak amplitude of ISO-stimulated ICa,L during exposure of the cells to various inhibitors of 161 
oxidative phosphorylation. Values are presented as means  SEM for the number of cells 162 
indicated in parentheses. * P<0.05 vs. ISO alone. 163 
 164 
Effect of intracellular ATP on ICa,L 165 
Inhibitors of cellular metabolism are expected to disturb ATP synthesis and therefore 166 
could lead to suppression of ICa,L due to insufficient intracellular ATP levels. Therefore, we 167 
evaluated the significance of the presence of ATP in the pipette solution for the maintenance 168 
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of ICa,L. In control conditions, when cells were dialyzed with a solution containing 3 mM 169 
ATP, the mean basal ICa,L amplitude was 3.1 ± 0.3 pA/pF (n=17). In the presence of ISO (1 170 
M), ICa,L increased ~7-fold to 20.0 ± 1.3 pA/pF (n=18). When ATP was excluded from the 171 
internal solution (Fig 3) the mean basal ICa,L amplitude was much lower (1.6 ± 0.1 pA/pF, 172 
n=4) and increased only by ~4-fold to 7.3 ± 1.7 pA/pF in the presence of ISO (n=4) (Fig 3B). 173 
Additionally, the lack of ATP in the internal solution also accelerated the spontaneous run-174 
down of ICa,L (Fig 3A). 175 
 176 
Fig 3. Effect of intracellular ATP on ICa,L amplitude. (A) A typical experiment 177 
representing the effect of ISO (1 µM) on basal ICa,L in the absence of ATP in pipette solution. 178 
The current traces shown on the top of the panel were recorded at the times indicated by the 179 
corresponding letters on the main graph. (B) Mean basal and ISO-stimulated ICa,L amplitudes 180 
recorded in cells dialyzed with 3 mM ATP and ATP-free internal solutions. *P<0.05, 181 
**P<0.01 for the number of cells indicated in parentheses. 182 
 183 
Role of ATP-synthase in the effect of metabolic inhibition on ICa,L 184 
The obvious explanation for the results obtained so far is that LTCCs require ATP to 185 
function properly and metabolic inhibition reduces ATP level because oxidative 186 
phosphorylation is stopped. However, one caveat to this hypothesis is that the inhibitory 187 
effects on ICa,L of all four metabolic inhibitors were observed even though 3 mM ATP was 188 
present in the patch pipette solution throughout the entire experiment. One would thus expect 189 
this permanent exogenous supply of ATP to minimize the role of endogenous ATP-synthase 190 
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activity. To specifically evaluate the contribution of this enzyme in the regulation of ICa,L, we 191 
examined the effect of oligomycin, an F1F0-ATP-synthase inhibitor. Oligomycin (30 M) 192 
had no effect on either basal (not shown) or ISO stimulated ICa,L (Fig 4). These results indicate 193 
that mitochondrial ATP production is not necessary for the activity of LTCCs, as long as 194 
ATP is supplied to the cell via the patch pipette. However, although oligomycin had no 195 
significant effect on ICa,L on its own, oligomycin strongly blunted the effect of FCCP (Fig 4A 196 
and 4B). In the same cells, washout of oligomycin recovered a strong inhibitory effect of 197 
FCCP on ICa,L. Thus, oligomycin strongly antagonized the inhibitory effect of FCCP on ICa,L. 198 
These results indicate that the activity of mitochondrial F1F0-ATPase contributes to the 199 
decrease in ICa,L during metabolic inhibition. Under normal conditions, the F1F0-ATPase 200 
complex is the site of mitochondrial ATP production. However, in the presence of a 201 
metabolic inhibitor such as FCCP electrical potential across the inner mitochondrial 202 
membrane is lost and the F1F0-ATPase complex may run backwards and consume ATP [26-203 
28]. This reverse activity may thus cause a local ATP depletion that leads to a reduction in 204 
ICa,L. 205 
 206 
Fig 4. Effect of oligomycin on ICa,L and its response to FCCP. (A) A typical experiment 207 
showing the effect of a pretreatment of the cell with oligomycin (30 µM) on ISO (1 µM)-208 
stimulated ICa,L and on the response to FCCP. (B) Mean amplitude of ISO-stimulated ICa,L 209 
recorded in the absence and presence of FCCP (100 nM) and oligomycin (30 µM). *P<0.05, 210 
**P<0.005. 211 
 212 
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Role of ATP depletion 213 
The effect of ATP depletion is expected to be more prominent during β-adrenergic 214 
stimulation, since ATP is required for cAMP production by adenylyl cyclase, and for 215 
phosphorylation of the LTCCs. To test this hypothesis, two series of experiments were 216 
performed. First, we tested the effect of FCCP in cells in which ICa,L was stimulated by direct 217 
intracellular application of cAMP (20 µM) via the patch pipette, thus bypassing the activation 218 
β-adrenergic receptor and adenylyl cyclase. Dialysis of the cell with cAMP stimulated ICa,L 219 
to 21.5 ± 4.2 pA/pF (n=4) and the amplitude of the current was not significantly different 220 
from that obtained with 1 µM ISO. Fig 5A shows that FCCP still produced a dose-dependent 221 
inhibition of ICa,L stimulated by cAMP, and the effect was not significantly different from the 222 
one observed when the current was stimulated by ISO. Thus, the suppression of ICa,L during 223 
metabolic inhibition does not involve a reduction in cAMP production due to lack of ATP, 224 
but rather involves mechanisms located downstream from -adrenergic receptor and adenylyl 225 
cyclase. In the second series of experiments, to test whether metabolic inhibition induced 226 
reduction in ICa,L is determined by insufficient phosphorylation of LTCCs, the patch pipette 227 
solution containing 3mM ATP was supplemented with the hydrolysis-resistant analogue of 228 
ATP, adenosine 5 ́-O-(3-thiotriphosphate) (ATP--S, 3 mM), which leads to irreversible 229 
thiophosphorylation of proteins [29]. Irreversible phosphorylation of LTCCs was confirmed 230 
by the observation that under these conditions ISO induced increase of ICa,L was maintained 231 
even after the prolonged washout of ISO (supplemental Fig S3 and S4). If during metabolic 232 
inhibition the decrease in ICa,L is caused by the reduced phosphorylation of LTCCs, then 233 
FCCP is expected to have no effect on ICa,L after irreversible thiophosphorylation of the 234 
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channels. However, as shown in Fig 5B, application of FCCP (100 nM) decreased ICa,L 235 
stimulated with ISO and ATP--S by 70.6 ± 4.1% (n=4), an effect which was not different 236 
from when the cells were dialyzed with ATP alone. Experimental traces demonstrating the 237 
effect of FCCP in cells dialyzed with ATP--S are shown in supplemental S3 Fig. These 238 
results indicate that protein dephosphorylation is not the cause of ICa,L reduction during 239 
metabolic inhibition. 240 
 241 
Fig 5. Role of channel phosphorylation in the effect of FCCP on ICa,L. (A) Comparison 242 
of the effect of a metabolic inhibition induced by FCCP on ICa,L stimulated by either ISO (1 243 
µM) or intracellular cAMP (20 M). (B) Comparison of the effect of FCCP on ISO-244 
stimulated ICa,L in the presence or absence of ATP--S (3 mM) in the pipette-filling solution. 245 
* P<0.05 and # p<0.05 vs absence of FCCP. 246 
 247 
Role of ATP hydrolysis 248 
So far, our results demonstrate that the regulation of ICa,L by metabolic inhibition 249 
involves the F1F0-ATPase complex but not the subsequent reduction in ATP. Therefore, we 250 
hypothesized that ATP hydrolysis is necessary in this process, possibly through changes in 251 
the concentration of one or several metabolites. To test this hypothesis, we examined whether 252 
FCCP still reduced ICa,L in cells dialysed with a solution containing only non-hydrolysable 253 
ATP analogues. In the experiment shown in Fig 6A, a frog ventricular cell was dialyzed with 254 
a pipette solution where ATP was replaced by a combination of 5'-adenylyl (β,γ-methylene) 255 
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diphosphonate (AMP-PCP, 3 mM) and ATP--S (0.5 mM). ATP--S was added to the 256 
solution only to allow for the stimulation of ICa,L by PKA upon application of ISO. As shown, 257 
inhibition of ICa,L by FCCP was completely abolished under these conditions. Even a 3-fold 258 
larger concentration of FCCP (300 nM, n=4, Fig 6A), or application of antimycin A (30 M, 259 
supplemental S4 Fig), failed to suppress ICa,L. Therefore, we conclude that ATP hydrolysis is 260 
required for the inhibition of ICa,L during metabolic inhibition. 261 
 262 
Fig 6. Non-hydrolysable ATP analogues prevent decrease of ICa,L by metabolic 263 
inhibition. (A) A typical experiment showing the absence of effect of FCCP (100 and 300 264 
nM) in a myocyte dialyzed with a pipette solution in which ATP was substituted with non-265 
hydrolysable ATP analogues AMP-PCP (3 mM) and ATP--S (0.5 mM). (B) Mean 266 
amplitudes of ICa,L recorded in control and with ISO (1 µM) during metabolic inhibition in 267 
cells dialyzed with 3 mM of ATP (white bars) or with non-hydrolysable ATP analogues (grey 268 
bars). *** P<0.001. 269 
 270 
Role of Mg2+ 271 
As ATP has a higher affinity for Mg2+ than ADP, ATP hydrolysis during metabolic 272 
inhibition can lead to a rise in cytosolic Mg2+ concentration ([Mg2+]i) [17] and [Mg
2+]i has 273 
been shown to reduce the activity of LTCCs [30-32]. To test for a possible role of [Mg2+]i 274 
changes in the effects of metabolic inhibitors on ICa,L, Mg
2+ in the pipette solution was 275 
substituted with Na+. The absence of Mg2+ in the internal solution led to an increase in basal 276 
 14  
ICa,L (7.7 ± 1.2 pA/pF (n=4) vs. 3.1 ± 0.4 pA/pF (n=7) in control), but no significant effect on 277 
the ISO-stimulated ICa,L was observed. In addition, FCCP (100 nM) still inhibited ICa,L in 278 
Mg2+-free solution similarly to when Mg2+ (4 mM) was present in the patch pipette solution 279 
(Fig 7). These results indicate that the effect of metabolic inhibition on ICa,L is not mediated 280 
by changes in [Mg2+]i. 281 
 282 
Fig 7. Effect of FCCP on ICa,L in cells dialyzed with zero-Mg2+ solution. Comparison of 283 
the response to ISO (1 µM) and to FCCP (30 and 100 nM) in the presence of ISO in the 284 
absence (white bars) or presence (black bars) of 4 mM Mg2+ in the pipette solution. *P<0.05. 285 
 286 
Role of intracellular acidosis 287 
Development of intracellular acidosis during metabolic inhibition in cardiomyocytes is 288 
well documented [3, 19, 20]. In order to investigate the contribution of acidosis in the effect 289 
of metabolic inhibition on ICa,L, myocytes were dialyzed with alkaline (pH 8.3) internal 290 
solution and the effect of FCCP on ICa,L was tested. Dialysis of myocytes with alkaline 291 
solution strongly attenuated the inhibitory effect of FCCP on ICa,L. As shown in Fig 8A, 300 292 
nM FCCP caused a significantly smaller decrease in ICa,L than 100 nM FCCP in cells dialysed 293 
with control solution with pH 7.3.  294 
To further examine the role of cytosolic acidification in the inhibitory effect of 295 
metabolic inhibition on ICa,L, the effect of FCCP was examined in cells dialysed with an 296 
internal solution with a low pH buffer concentration (1 mM HEPES instead of 10 mM in 297 
control conditions). As expected, reducing the pH buffering capacity in the pipette solution 298 
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amplified the inhibitory effect of FCCP on ICa,L as evidenced by a shift to lower FCCP 299 
concentrations of the concentration-response curve for the effect of FCCP on ISO-stimulated 300 
ICa,L (Fig 8B). Thus, we conclude that the main cause for ICa,L inhibition in frog ventricular 301 
myocytes during metabolic inhibition is due to ATP hydrolysis causing an intracellular 302 
acidosis in the vicinity of LTCCs. 303 
 304 
Fig 8. Effect of intracellular pH on ICa,L response to metabolic inhibition. (A) Effect of 305 
100 and 300 nM of FCCP on ISO (1 µM)-stimulated ICa,L in cells dialyzed with either control 306 
(pH 7.3, white bar) or alkaline solution (pH 8.3, black bars). * P<0.05. (B) (a) Effect of three 307 
different FCCP concentrations (30, 50 and 100 nM) on ISO (1 µM)-stimulated ICa,L in a 308 
ventricular myocyte dialysed with low HEPES (1 mM) intracellular solution. (b) 309 
Concentration-response curves for the effects of FCCP on ISO-stimulated ICa,L in cells 310 
dialysed with a solution containing either 1 mM (n=3 to 7, white squares) or 10 mM HEPES 311 
(n=4, black diamonds). 312 
 313 
Discussion 314 
This study investigates the effect of metabolic inhibition on ICa,L in frog ventricular 315 
myocytes. The key findings are as follows: first, metabolic inhibition caused a reduction of 316 
both basal and ISO stimulated ICa,L, but ISO stimulated cells were more sensitive to metabolic 317 
inhibition. Second, the effect of metabolic inhibition on ICa,L was strongly attenuated by the 318 
inhibition of mitochondrial F1F0-ATP synthase and intracellular dialysis with non-319 
hydrolysable ATP analogues. These findings indicate that the observed effects were not 320 
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caused by impaired ATP production, but were rather due to profound ATP hydrolysis by 321 
F1F0-ATP synthase operating in the reverse mode. Finally, our results demonstrate that 322 
increased intracellular acidification is the primary cause of ICa,L inhibition.  323 
After the onset of coronary occlusion, ischemic myocardium quickly loses its 324 
contractile function and electrical instability can lead to ventricular fibrillation and sudden 325 
cardiac death. Mitochondria are known to be a central player in myocardial ischemic injury 326 
[33]. Ischemia-induced loss of electrical potential across the inner mitochondrial membrane 327 
results in the suppression of oxidative phosphorylation, ATP depletion and opening of the 328 
mitochondrial permeability transition pore and mitochondrial apoptosis channels resulting in 329 
myocyte apoptosis and necrosis [33, 34]. It is also well documented that hypoxia leads to the 330 
reversible LTCC inhibition [35-38]. Interestingly, under hypoxic condition, increased 331 
sensitivity of ICa,L to β-adrenergic stimulation was observed in single cardiomyocytes [36, 332 
37] as well as in isolated heart [39]. Similar sensitization of LTCCs to β-adrenergic 333 
stimulation was also reported when mitochondrial function was inhibited with myxothiazol 334 
or FCCP [37]. However, the cellular and molecular mechanisms underlying the effects of 335 
hypoxia on activity of LTCCs remain incompletely understood. An important role of protein 336 
kinase C in the modulation of the sensitivity of the channel to β-adrenergic receptor 337 
stimulation was suggested [36]. Additionally, it was reported that pre-exposure of the 338 
myocytes to extracellular hydrogen peroxide attenuated both the inhibition of basal ICa,L and 339 
the increase in sensitivity of ICa,L to β-adrenergic stimulation during hypoxia suggesting that 340 
hypoxia mediates changes in channel activity and sensitivity to adrenergic stimulation by a 341 
lowering in hydrogen peroxide levels [37]. As an alternative hypothesis, it was proposed that 342 
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decrease of ICa,L during hypoxia is mediated by the binding of haem oxygenase to the 343 
CaM/CaMKII-specific motifs of LTCCS [38].  344 
Pharmacologically induced metabolic inhibition was demonstrated to lead to 345 
development of action potential and Ca2+ alternans in the heart [40, 41] and to increase 346 
vulnerability to arrhythmias [42]. Metabolic inhibition-induced changes in excitation-347 
contraction coupling are well documented [3, 4, 15, 43]. It was demonstrated that metabolic 348 
inhibition affects properties of intracellular Ca2+ release and decreases frequency of 349 
spontaneous Ca2+ waves [2, 3]. The reports on the changes in SR Ca2+ load during metabolic 350 
inhibition are rather inconsistent as some studies have reported no change or decrease in SR 351 
Ca2+ content [4, 5] while others demonstrated increase in SR Ca2+ load [2]. Such 352 
discrepancies in the results can be at least partially explained by the reported biphasic effect 353 
of metabolic inhibition on intracellular Ca2+ signaling, consisting of an initial inhibition 354 
followed by stimulation of SR Ca2+ release [3]. The primary focus of this study was to 355 
examine the effect of metabolic inhibition on the activity of LTCCs, which serve as a trigger 356 
for Ca2+-induced Ca2+-release in mammalian cardiomyocytes. Metabolic inhibition leads to 357 
the decrease in ICa,L amplitude [3, 4]. Single channels recordings have revealed that metabolic 358 
inhibition reduces open probability, mean open time and delays activation of LTCCs [15]. 359 
However, the mechanisms underlying the suppression of ICa,L are poorly understood. It was 360 
suggested that the depletion of ATP during metabolic inhibition might lead to a decrease in 361 
phosphorylation of the channels which is essential to maintain normal function of LTCCs 362 
[44, 45]. In contrary, others studies have demonstrated that intracellular perfusion with non-363 
hydrolysable analogues of ATP can successfully prevent ICa,L suppression, arguing against 364 
the channel phosphorylation hypothesis and an allosteric modulation of the channel by ATP 365 
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was proposed [46, 47]. The importance of ATP in sustaining normal ICa,L is also confirmed 366 
by our experiments where dialysis of the cells with ATP free solution caused a decrease in 367 
both basal and ISO stimulated current amplitudes and an increase in current rundown (Fig 368 
3). However, this observation can hardly explain the fact that wide array of oxidative 369 
phosphorylation inhibitors induced suppression of LTCCs even when the cell was dialysed 370 
with a solution containing 3 mM of ATP (Fig 1C). In addition, when ICa,L was stimulated by 371 
intracellular application of cAMP, FCCP suppressed ICa,L in a manner similar to ISO 372 
stimulated cells (Fig 5), suggesting that the effect of FCCP on ICa,L was independent of the 373 
activity of -adrenergic receptors or adenylyl cyclase. When the myocytes were dialyzed 374 
with a pipette solution containing both ATP and ATP--S, which leads to irreversible protein 375 
thio-phosphorylation [29], FCCP still induced an inhibition of ICa,L (Fig 5). Therefore, it is 376 
reasonable to conclude that the effects of metabolic inhibition on ICa,L are not related to 377 
decreased phosphorylation of the channels. 378 
While inhibition of mitochondrial F1F0-ATP-synthase alone had only minor effect on 379 
ICa,L, we observed that it strongly attenuated the inhibitory effect of FCCP (Fig 4). Under 380 
normal conditions, F1F0-ATP-synthase is the site of ATP production. However, it was 381 
suggested that during ischemia or pharmacological inhibition of the oxidative 382 
phosphorylation F1F0-ATP-synthase, in an attempt to maintain the mitochondrial membrane 383 
potential, begins to run reverse becoming a powerful ATP consumer [26-28]. Furthermore, 384 
it was demonstrated that a block of F1F0-ATP-synthase might be beneficial during ischemic 385 
or anoxic conditions [28, 48]. To further confirm that ATP hydrolysis is necessary to suppress 386 
ICa,L during metabolic inhibition, the effect of FCCP was examined in cells dialysed with a 387 
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pipette-filling solution containing only non-hydrolysable ATP analogues AMP-PCP and 388 
ATP--S. Non-hydrolysable ATP analogues completely prevented inhibition of ICa,L during 389 
metabolic inhibition (Fig 6) clearly demonstrating that suppression of ICa,L during metabolic 390 
inhibition is associated with the intensive ATP hydrolysis by F1F0 ATP-synthase.  391 
Metabolic inhibition as well as ischemia results in intracellular acidification [3, 19, 49, 392 
50]. Intracellular acidosis in cardiomyocytes was demonstrated to regulate various processes 393 
including Ca2+-induced Ca2+-release [49], activity of ion channels [51], gap junctions [52] 394 
and phosphorylation levels [19]. Previous studies exploring the effect of acidosis on LTCC 395 
activity led to conflicting results, with studies showing either inhibition [53-55], no apparent 396 
effect [51, 56] or increase in ICa,L [57]. The reasons for such conflicting results remain unclear 397 
and might be related to the experimental approaches used to induce intracellular acidosis 398 
and/or to species differences. Furthermore, the changes in intracellular pH may not be 399 
uniform within the cell. For instance, the close colocalization of mitochondria with SR and 400 
plasma membrane [21, 22] may form restricted domains where metabolic inhibition causes 401 
higher changes in pH. In our study, acidosis was induced by metabolic inhibition and this 402 
resulted in an inhibition of ICa,L which was much more pronounced during β-adrenergic 403 
stimulation. Interestingly, in an earlier study performed in guinea-pig ventricular myocytes, 404 
the maximal response to isoprenaline, forskolin or intracellular cAMP was also found to be 405 
strongly reduced in myocytes pretreated with acidic external solution [58]. Our results that 406 
both high intracellular pH buffering capacity and intracellular dialysis of myocytes with 407 
alkaline solution can mitigate metabolic inhibition-induced suppression of β-adrenergic 408 
response of LTCCs (Fig 8) suggest an essential role of acidosis in this process. 409 
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Conclusions 410 
Our data demonstrate that metabolic inhibition leads to excessive ATP hydrolysis by 411 
the mitochondrial F1F0-ATP-synthase operating in the reverse mode which results in 412 
intracellular acidosis (Fig 9). We suggest that acidosis plays a key role in the suppression of 413 
LTCC activity during metabolic inhibition, and this contributes to the mechanisms of 414 
ischemic injury. 415 
 416 
Fig 9. Schematic representation of the metabolic inhibition of cardiac ICa,L. Metabolic 417 
inhibition leads to the depolarization of mitochondrial membrane potential. Under these 418 
conditions the mitochondrial F1F0-ATP synthase operates in the reverse-mode and intensive 419 
ATP hydrolysis results in intracellular acidification which in turn reduces ICa,L. 420 
421 
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Supporting information  610 
S1 Fig. FCCP induced suppression of basal ICa,L. (A) Dose dependent effect of FCCP 611 
on the peak amplitude of ICa,L. (B) The mean peak amplitude of basal ICa,L in control and 612 
during exposure of myocytes to the increasing FCCP concentration (n=5) . * P<0.05 vs. 613 
control. 614 
S2 Fig. Effect of NaN3 on basal and ISO stimulated ICa,L. A typical experiment 615 
representing effect of NaN3 on the peak amplitude of basal and ISO-stimulated ICa,L. The 616 
current traces shown in the top panel were recorded at times indicated by the corresponding 617 
letters on the main graph.  618 
S3 Fig. Effect of FCCP on ICa,L in the cells dialyzed with ATP-γ-S. A time course of 619 
changes in ICa,L peak amplitude during the application of increasing FCCP concentrations 620 
to the ventricular myocytes dialyzed with internal solution containing 3 mM ATP and 621 
supplemented with 3 mM of ATP-γ-S. A transient application of ISO was used to induce 622 
irreversible thiophosphorylation of proteins. The current traces shown in the top panel were 623 
recorded at times indicated by the corresponding letters on the main graph. 624 
S4 Fig. Dialysis with non-hydrolysable ATP analogues prevents suppression of ICa,L 625 
by antimycin. An experiment demonstrating the lack of ICa,L suppression in the presence of 626 
30 µM of antimycin in a myocyte dialyzed with a pipette solution in which ATP was 627 
substituted with non-hydrolysable ATP analogues AMP-PCP (3 mM) and ATP--S (0.5 628 
mM). The current traces shown in the top panel were recorded at times indicated by the 629 
corresponding letters on the main graph.  630 
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S1 Fig. FCCP induced suppression of basal ICa,L.
(A) Dose dependent effect of FCCP on the peak amplitude of ICa,L. (B) The mean peak amplitude
of basal ICa,L in control and during exposure of myocytes to the increasing FCCP concentration
(n=5). * P<0.05 vs. control.
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S2 Fig. Effect of NaN3 on basal and ISO stimulated ICa,L.
A typical experiment representing effect of NaN3 on the peak
amplitude of basal and ISO-stimulated ICa,L. The current traces
shown in the top panel were recorded at times indicated by the
corresponding letters on the main graph.
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S3 Fig. Effect of FCCP on ICa,L in the cells dialyzed with ATP-γ-S.
A time course of changes in ICa,L peak amplitude during ISO stimulation
and during the application of increasing FCCP concentrations to the
ventricular myocytes dialyzed with internal solution containing 3mM ATP
and supplemented with 3 mM of ATP-γ-S. The current traces shown in the
top panel were recorded at times indicated by the corresponding letters on
the main graph.
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S4 Fig. Dialysis with non-hydrolysable ATP analogues prevents
suppression of ICa,L by antimycin.
An experiment demonstrating the lack of ICa,L suppression in the
presence of 30 µM of antimycin in a myocyte dialyzed with a pipette
solution in which ATP was substituted with non-hydrolysable ATP
analogues AMP-PCP (3 mM) and ATP--S (0.5 mM). The current
traces shown in the top panel were recorded at times indicated by the
corresponding letters on the main graph.
